Methylenedioxyphentermine
| Methylenedioxyphentermine | |
|---|---|
|
2-Benzo[1,3]dioxol-5-yl-1,1-dimethylethylamine |
|
|
Other names
3,4-Methylenedioxyphentermine; |
|
| Identifiers | |
| CAS number | 39235-63-7 |
| Jmol-3D images | Image 1 |
|
|
| Properties | |
| Molecular formula | C11H15NO2 |
| Molar mass | 193.24 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references |
3,4-Methylenedioxyphentermine (MDPH) is a lesser-known psychedelic drug. MDPH was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 160-240 mg, and the duration as 3–5 hours. MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.
[edit] See also
[edit] References
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (July 2009) |
[edit] External links
|
|
| This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |

